Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
International Business Machines Corporation's published Hold conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $221.3B | |
|---|---|---|
| Revenue (ttm) | 69.9B | |
| Net income (ttm) | 11.2B | |
| EPS (ttm) | $11.7 | |
| Shares out | 945.1M | |
| P/E (trailing) | 21.6x | |
| P/E (forward) | 17.6x | |
| Dividend | $6.76 (2.67%) | |
| Volume | 2,696,553 | |
| Beta | 0.72 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $57.35B | $60.53B | $61.86B | $62.75B | $67.54B | +4.2% |
| Gross profit | $31.49B | $32.69B | $34.30B | $35.55B | $39.30B | +5.7% |
| Operating income | $7.02B | $2.37B | $7.51B | $7.51B | $12.26B | +15.0% |
| Net income | $5.74B | $1.64B | $7.50B | $6.02B | $10.59B | +16.5% |
| EPS (diluted) | $6.35 | $1.80 | $8.14 | $6.43 | $11.17 | +15.2% |
| EBITDA | $13.44B | $7.17B | $7.51B | $12.18B | $17.28B | +6.5% |
| R&D | $6.49B | $6.57B | $6.78B | $7.48B | $8.32B | +6.4% |
| SG&A | $18.75B | $18.61B | $19.00B | $19.69B | $20.12B | +1.8% |
Recent company headlines from major financial publishers.
This path requires modest sales growth and stable margins. Weaker cash generation or estimate delivery would disconfirm it.
Sustained estimate delivery and dated support beyond FY2027 would keep upside alive. Weaker estimates or cash generation would disconfirm it.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.2% | $271 | $294 | $325 | $368 | $435 |
| 6.2% | $231 | $244 | $261 | $283 | $312 |
| 7.2% | $204 | $212 | $224 | $235 | $251 |
| 8.2% | $184 | $190 | $197 | $205 | $215 |
| 9.2% | $169 | $173 | $178 | $183 | $190 |
Upcoming earnings date and setup when available.
The rating each month's published research edition carried. A rating compares the price at analysis with the Fair value; it is not a record of whether the call was right.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
